Pfizer

Pfizer refiles Seagen deal paperwork with regulators
BioPharma Dive
Wed, 06/14/23 - 06:52 pm
Pfizer
Seagen
FTC
M&A
Pfizer and GSK to battle for share of new RSV vaccine market
Biopharma Reporter
Wed, 06/14/23 - 11:33 am
Pfizer
GSK
FDA
vaccines
RSV
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
'I don't have a checklist:' Seagen CEO talks about his next stop, Pfizer deal and the ADC landscape
Fierce Pharma
Thu, 06/8/23 - 09:34 pm
Seagen
Pharma CEOs
David Epstein
Pfizer
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Pharmaceutical Business Review
Thu, 06/8/23 - 09:45 am
Samsung BioLogics
Pfizer
biosimilars
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Sanofi
AstraZeneca
GSK
Pfizer
RSV
vaccines
FDA
Moderna, Pfizer Hit with New COVID Vaccine Patent Lawsuits
BioSpace
Wed, 06/7/23 - 09:35 pm
Moderna
Pfizer
patents
MRNA
Promosome
legal
COVID-19
vaccines
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Pfizer
danuglipron
Novo Nordisk
Ozempic
weight loss
Pfizer says antibiotic is effective against tough-to-treat infections
BioPharma Dive
Fri, 06/2/23 - 11:23 am
Pfizer
antibiotics
clinical trials
drug-resistant infections
ATM-AVI
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Thu, 06/1/23 - 06:41 pm
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
FDA approves Pfizer’s RSV vaccine for older adults
Stat
Wed, 05/31/23 - 07:03 pm
Pfizer
vaccines
FDA
elderly
RSV
Abrysvo
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Tue, 05/30/23 - 09:28 pm
Alnylam Pharmaceuticals
legal
patents
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Tue, 05/30/23 - 10:07 am
Pfizer
Novo Nordisk
clinical trials
hemophilia
marstacimab
Pfizer's Heading for a Patent Cliff
Motley Fool
Tue, 05/30/23 - 09:45 am
Pfizer
patents
patent cliff
Pfizer’s etrasimod aims to differentiate UC market with strong safety profile
Clinical Trials Arena
Fri, 05/26/23 - 11:12 am
Pfizer
etrasimod
ulcerative colitis
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
Fri, 05/26/23 - 09:46 am
RSV
vaccines
elderly
Pfizer
GSK
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
CNBC
Thu, 05/25/23 - 08:28 pm
Pfizer
Paxlovid
COVID-19
FDA
antivirals

Pages